Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Wakefield

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cellsT Masui, L M Wakefield, J F Lechner, et al.
Breast Cancer Research : BCR|March 16, 2001
Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model systemJ Zujewski, A Vaughn-Cooke, K C Flanders, et al.
The Journal of Clinical Investigation|December 1, 1990
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distributionL M Wakefield, T S Winokur, R S Hollands, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1986
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytesJ H Kehrl, A B Roberts, L M Wakefield, et al.
Journal of Cellular Physiology|May 1, 1994
Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF-betaR T Ballock, A Heydemann, L M Wakefield, et al.
Developmental Biology|August 1, 1993
TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteasesR T Ballock, A Heydemann, L M Wakefield, et al.
Cell|February 13, 1987
Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cellsC Knabbe, M E Lippman, L M Wakefield, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1985
Type beta transforming growth factor: a bifunctional regulator of cellular growthA B Roberts, M A Anzano, L M Wakefield, et al.
Molecular Carcinogenesis|November 14, 2000
Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1Y Kang, J M Mariano, J Angdisen, et al.
The Journal of Biological Chemistry|July 5, 1992
Post-transcriptional regulation of the human transforming growth factor-beta 1 geneS J Kim, K Park, D Koeller, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cellsT Masui, L M Wakefield, J F Lechner, et al.
Breast Cancer Research : BCR|March 16, 2001
Transforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model systemJ Zujewski, A Vaughn-Cooke, K C Flanders, et al.
The Journal of Clinical Investigation|December 1, 1990
Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distributionL M Wakefield, T S Winokur, R S Hollands, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1986
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytesJ H Kehrl, A B Roberts, L M Wakefield, et al.
Journal of Cellular Physiology|May 1, 1994
Inhibition of the chondrocyte phenotype by retinoic acid involves upregulation of metalloprotease genes independent of TGF-betaR T Ballock, A Heydemann, L M Wakefield, et al.
Developmental Biology|August 1, 1993
TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteasesR T Ballock, A Heydemann, L M Wakefield, et al.
Cell|February 13, 1987
Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cellsC Knabbe, M E Lippman, L M Wakefield, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1985
Type beta transforming growth factor: a bifunctional regulator of cellular growthA B Roberts, M A Anzano, L M Wakefield, et al.
Molecular Carcinogenesis|November 14, 2000
Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1Y Kang, J M Mariano, J Angdisen, et al.
The Journal of Biological Chemistry|July 5, 1992
Post-transcriptional regulation of the human transforming growth factor-beta 1 geneS J Kim, K Park, D Koeller, et al.
Pageof 7